行情

CTLT

CTLT

Catalent
NYSE

实时行情|Nasdaq Last Sale

62.85
+0.85
+1.37%
交易中 13:20 01/28 EST
开盘
62.32
昨收
62.00
最高
63.07
最低
61.59
成交量
27.12万
成交额
--
52周最高
63.07
52周最低
35.53
市值
91.96亿
市盈率(TTM)
64.22
分时
5日
1月
3月
1年
5年

分析师评级

10位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CTLT 新闻

  • Catalent (CTLT) Reports Next Week: What You Should Expect
  • Zacks.1天前
  • Stephens & Co. Maintains Overweight on Catalent, Raises Price Target to $75
  • Benzinga.1天前
  • Calculating The Fair Value Of Catalent, Inc. (NYSE:CTLT)
  • Simply Wall St..1天前
  • The Best Big Cap Stocks To Buy
  • Seeking Alpha - Article.3天前

更多

所属板块

制药
+0.37%
制药与医学研究
+0.54%

热门股票

名称
价格
涨跌幅

CTLT 简况

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.
展开

Webull提供Catalent Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。